financetom
Business
financetom
/
Business
/
Update: Spectra7 Microsystems Raising Up to C$10.2 Million in First Tranche of Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Spectra7 Microsystems Raising Up to C$10.2 Million in First Tranche of Private Placement
May 6, 2024 9:45 AM

12:18 PM EDT, 05/06/2024 (MT Newswires) -- Spectra7 Microsystems ( SPVNF ) said Monday it is raising up to $10.2 million in the first tranche of a private placement, with closing expected about May 8.

The analog semiconductor company said it may complete subsequent tranches of the private placement to increase the proceeds to up to C$24 million.

Spectra7 plans to use the proceeds for working capital and general corporate purposes. The company said the funds would improve its capital structure, allowing it to support hyperscaler customer needs.

The offering comprises 102-million units priced at $0.10. Each unit consists of either one share and one warrant or one pre-funded common share purchase warrant and one warrant if the share ownership threshold would be exceeded by a subscriber.

Each warrant can be exercised immediately at $0.11 per share.

Spectra7 also outlined certain amendments to its $8.873 million in 14% unsecured convertible debentures and its existing $2.828 million in 9% unsecured convertible debentures.

"We are pleased that the anticipated conversion of the outstanding debentures into common Shares and warrants, together with the new issuance of units, will simplify the capital structure of the company, eliminate interest payments on debentures, and provide additional capital for operations," Chairman Ron Pasek said.

Spectra7's shares were last seen down C$0.01 to C$0.12 on the TSX Venture Exchange.

Price: 0.12, Change: -0.01, Percent Change: -7.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved